Summary
FY4/2026 was an irregular six-month fiscal period following a change in fiscal year-end, ending with revenue of JPY 21,006M, operating income of JPY 3,812M, and an OPM of 18.1%. For FY4/2027, management guides for the YoY increase in matching service revenue to inflect higher in both the first and second halves, and has disclosed full-year revenue guidance in a range of JPY 47,613–48,823M. At the same time, the company plans to front-load upfront investment in the logistics field manager business and the nursing care/welfare sector into the first half, making 1Q a quarter in which re-accelerating top-line growth and investment burden appear simultaneously. Trends in core KPIs such as the 85.9% utilization rate and JPY 69,475M in GMV, along with the persistence of the higher cost-of-sales ratio, will be key to gauging the likelihood of hitting the 1H cumulative plan (revenue of JPY 22,056–22,560M).
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
Revenue GrowthYoY increase in 1Q revenue and progress against the 1H cumulative plan | Year-ago revenue (May–Jul 2025) was JPY 8,367M (our estimate). The 1H cumulative plan of JPY 22,056–22,560M implies +23.7% to +26.5% (our estimate) versus the year-ago six-month figure of JPY 17,829M; the key question is whether 1Q growth falls within this range. |
Core KPIsUtilization rate, GMV, registered workers / registered client sites | Last period saw a utilization rate of 85.9%, GMV of JPY 69,475M, over 14.20M registered workers, and over 465,000 registered client sites. Sustaining a high utilization rate is critical to revenue quality. |
ProfitabilityOPM and the extent to which front-loaded 1H investment is reflected | OPM was 18.1% last period and 16.8% in the immediately preceding quarter (Feb–Apr 2026, our estimate). We look for consistency with the 18.1%–19.5% OPM implied by the 1H cumulative plan (our estimate). |
Cost StructureTrends in cost-of-sales ratio and gross profit margin | Last period's gross profit margin of 91.7% was down from 94.4% in FY10/2025. Whether the cost ratio stabilizes at this level in 1Q determines the scope for reaching the upper end of the operating income range. |
Financials / Working CapitalAdvance payments balance, short-term borrowings, operating CF | Period-end advance payments were JPY 12,612M and short-term borrowings JPY 13,500M. We will watch the pace of increase in the advance funding burden accompanying GMV growth and its relationship with operating CF. |
Key Issues from Previous Results (FY4/2026 Full-Year Results)
FY4/2026 was an irregular six-month fiscal period (Nov 1, 2025–Apr 30, 2026) due to the change in fiscal year-end, with revenue of JPY 21,006M, operating income of JPY 3,812M, recurring profit of JPY 3,760M, and Net Income Attributable to Owners of Parent Company of JPY 2,439M. No comparison with the prior consolidated fiscal year is provided, making a quarterly read of underlying trends all the more important. For FY4/2027, the key issue is balancing re-accelerating growth in the matching service with first-half-weighted investment in the logistics and nursing care/welfare domains.
1. Inflection in the YoY Increase in Matching Service Revenue
- Last Period: Of total revenue of JPY 21,006M, the Timee business segment generated JPY 20,370M in revenue (external customers) and segment profit of JPY 3,919M. Management explicitly states its assumption that "the YoY increase, which had been on a declining trend, will inflect higher in both the first and second halves."
- What To Watch This Period: How large the increase in 1Q (May–Jul 2026) revenue is versus the year-ago JPY 8,367M (our estimate), as an early sign of the inflection.
- Key Metrics: 1Q revenue YoY growth, and progress against the 1H cumulative plan of JPY 22,056–22,560M (+23.7% to +26.5% versus the year-ago six-month period, our estimate).
2. Core KPI Trends Centered on Utilization Rate and GMV
- Last Period: The utilization rate was maintained at 85.9%, with GMV of JPY 69,475M, over 14.20M registered workers, and over 465,000 registered client sites. Revenue as a percentage of GMV was 30.2% (our estimate).
- What To Watch This Period: Whether the expanded deployment of field managers in logistics and marketing investment in nursing care/welfare can keep filled positions growing in line with job postings. Management has outlined a policy of deploying worker marketing spend to keep utilization high at sites where job postings are surging.
- Key Metrics: 1Q utilization rate, GMV, registered workers, and registered client sites versus the prior period-end.
3. First-Half-Weighted Upfront Investment and OPM
- Last Period: OPM of 18.1%; operating income in the immediately preceding quarter (Feb–Apr 2026) was JPY 1,704M for an OPM of 16.8% (our estimate). SG&A totaled JPY 15,460M.
- What To Watch This Period: Management plans to front-load personnel costs from aggressive field manager hiring, along with worker marketing spend in logistics and nursing care/welfare, into the first half. We will assess how much of this cost front-loading shows up in margins as early as 1Q.
- Key Metrics: 1Q OPM and absolute SG&A, and consistency with the 1H cumulative operating income plan of JPY 3,997–4,388M (implying an OPM of 18.1%–19.5% under that plan, our estimate).
4. Rising Cost-of-Sales Ratio and the Level of Gross Profit Margin
- Last Period: Cost of goods sold of JPY 1,733M and a gross profit margin of 91.7%. This is down from 94.4% in FY10/2025, with the cost ratio rising from 5.6% to 8.3% (our estimate).
- What To Watch This Period: The higher cost ratio is primarily attributable to the consolidation of Timee Solutions, which operates a contracting business.
- Key Metrics: 1Q cost of goods sold and gross profit margin, compared with the 91.7% posted for the prior full period.
5. Working Capital and Capital Allocation Amid Growing Advance Payments
- Last Period: Advance payments of JPY 12,612M (+JPY 767M versus the prior period-end), short-term borrowings of JPY 13,500M (+JPY 2,390M), operating CF of JPY 1,283M, and cash and cash equivalents of JPY 16,530M. Cumulative share buybacks as of May 31, 2026 totaled 1,007,200 shares for JPY 1,275M.
- What To Watch This Period: Whether the structure of funding GMV-linked growth in advance payments via short-term borrowings persists, alongside the company's operating cash generation. The 183,200 shares repurchased for JPY 224M between May 1–7, 2026 will be reflected in 1Q. Note also that a JPY 354M valuation loss on investment securities was booked as an extraordinary loss; the presence of any extraordinary items in 1Q also warrants attention.
- Key Metrics: End-1Q advance payments balance, short-term borrowings balance, and equity ratio (42.4% at the prior period-end).
Timely Disclosure & Industry Trends
- 2026/08/27Co-creation partnership with Zeals for creating new jobs in the physical AI era - Still at the exploratory stage of creating a new spot-work category, so the contribution to 1Q earnings is limited. Positioned as a stepping stone for medium-term expansion of job categories. Co-creation partnership with Zeals for creating new jobs in the physical AI era
- 2026/08/03(Progress of Disclosed Matter) Notice regarding company split (simplified absorption-type split) to a wholly owned subsidiary - The field manager business and related operations were transferred to a subsidiary effective August 1, 2026. As a transaction under common control, the impact on consolidated P&L is limited, but segment presentation is a point to check from 2Q. (Progress of Disclosed Matter) Notice regarding company split (simplified absorption-type split) to a wholly owned subsidiary
- 2026/07/30Full-scale rollout of the new "Long-Term Part-Time Hiring Support Plan" from August 1, 2026 - One of the initiatives management cites as underpinning the upper end of full-year guidance. As the full rollout begins August 1, revenue contribution will only become visible from 2Q. Full-scale rollout of the new "Long-Term Part-Time Hiring Support Plan" from August 1, 2026
Previous Quarter Results (FY4/2026 Full-Year Actuals)
The company's core business is a fee-based employment placement operation that runs "Timee," a nationwide spot-work service matching "hours people want to work" with "hours employers need covered," brokering direct day-by-day employment between clients and workers. FY4/2026 was an irregular six-month fiscal period following the change in fiscal year-end. Registered client sites and active accounts grew, led by logistics and retail, while the utilization rate was maintained at 85.9%. In its focus areas, the company expanded field manager headcount in logistics and built out its foundation in nursing care/welfare, and for FY4/2027 plans first-half-weighted upfront investment aimed at re-accelerating growth.
| Item | Amount | YoY | vs. Guidance | Notes |
|---|---|---|---|---|
| Revenue | JPY 21,006M | - | - | No prior-period comparison given the irregular six-month period. GMV of JPY 69,475M |
| Operating Income | JPY 3,812M | - | - | OPM of 18.1%, gross profit margin of 91.7% |
| Recurring Profit | JPY 3,760M | - | - | Interest expense of JPY 76M |
| Net Income | JPY 2,439M | - | - | Extraordinary losses include a JPY 354M valuation loss on investment securities |
| EPS | JPY 24.25 | - | - | Diluted EPS of JPY 22.93 |
Guidance Achievement Rate (Recurring Profit Basis): Not calculable, as no corresponding company plan for FY4/2026 (the irregular six-month period) is disclosed in this earnings release. FY4/2027 recurring profit guidance is JPY 8,806–9,731M (1H cumulative: JPY 3,986–4,377M).
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.